What's New on the FDA Drugs Site
November 19, 2009
New and Generic Drug Approvals
November 19, 2009
- Adenocard (adenosine) Injection, Astellas Pharma US, Inc., Labeling Revision
- Methocarbamol Tablets, Hetero Drugs Ltd. Unit III, Approval
- Nicardipine Hydrochloride Injection, PharmaForce, Inc., Approval
- Nicardipine Hydrochloride Injection, GeneraMedix, Inc., Approval
- Nicardipine Hydrochloride Injection, Navinta, LLC., Approval
- Nicardipine Hydrochloride Injection, Sun Pharma Global Inc., Approval
- Nicardipine Hydrochloride Injection, Wockhardt Limited, Approval
- Norethindrone Acetate and Ethinyl Estradiol Tablets, Barr Laboratories, Inc., Approval
- RETROVIR (zidovudine) Capsules, GlaxoSmithKline, Labeling Revision
- RETROVIR (zidovudine) Syrup, GlaxoSmithKline, Efficacy Supp. w/Clinical Data
- Truvada (emtricitabine and tenofovir disoproxil fumarate) Tablets, Gilead Sciences, Inc., Labeling Revision
- Zestril (lisinopril) Tablets, AstraZeneca Pharmaceuticals, Labeling Revision
- Zestoretic (lisinopril and hydrochlorothiazide) Tablets, AstraZeneca Pharmaceuticals, Labeling Revision
- Ziac (bisoprolol fumarate and hydrochlorothiazide) Tablets, Duramed Pharmaceuticals, Inc., Labeling Revision
Manage your FDA Subscriptions:
- Update your preferences or unsubscribe
- Questions about this service? support@govdelivery.com
- Other inquiries? webmail@oc.fda.gov
GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420
0 comments:
Post a Comment